Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 26 | 2023 | 74 | 9.580 |
Why?
|
| Thalamus | 7 | 2023 | 28 | 4.510 |
Why?
|
| Subthalamic Nucleus | 12 | 2023 | 32 | 4.170 |
Why?
|
| Parkinson Disease | 16 | 2023 | 1164 | 2.800 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 5 | 2019 | 11 | 2.280 |
Why?
|
| Microelectrodes | 8 | 2020 | 36 | 2.020 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 81 | 1.900 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2020 | 7 | 1.490 |
Why?
|
| Neurosurgical Procedures | 5 | 2022 | 150 | 1.490 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2021 | 16 | 1.480 |
Why?
|
| Neuronavigation | 3 | 2019 | 6 | 1.460 |
Why?
|
| Prosthesis Implantation | 3 | 2017 | 33 | 1.450 |
Why?
|
| Implantable Neurostimulators | 2 | 2020 | 14 | 1.380 |
Why?
|
| Humans | 53 | 2023 | 29337 | 1.320 |
Why?
|
| Epilepsy | 2 | 2020 | 104 | 1.310 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2023 | 1221 | 1.240 |
Why?
|
| White Matter | 2 | 2021 | 149 | 1.230 |
Why?
|
| Essential Tremor | 3 | 2023 | 15 | 1.140 |
Why?
|
| Brain | 4 | 2021 | 1689 | 1.130 |
Why?
|
| Stereotaxic Techniques | 5 | 2020 | 27 | 1.050 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2019 | 770 | 1.040 |
Why?
|
| Female | 30 | 2022 | 16197 | 1.020 |
Why?
|
| Male | 28 | 2022 | 15621 | 0.930 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2021 | 46 | 0.860 |
Why?
|
| Middle Aged | 22 | 2022 | 9823 | 0.860 |
Why?
|
| Hematoma | 1 | 2022 | 19 | 0.850 |
Why?
|
| Aged | 19 | 2022 | 9448 | 0.810 |
Why?
|
| Tremor | 1 | 2023 | 141 | 0.810 |
Why?
|
| Hand | 2 | 2019 | 45 | 0.810 |
Why?
|
| Monitoring, Intraoperative | 3 | 2022 | 37 | 0.800 |
Why?
|
| Neurosurgery | 2 | 2020 | 49 | 0.790 |
Why?
|
| Electrodes, Implanted | 5 | 2019 | 46 | 0.790 |
Why?
|
| Third Ventricle | 1 | 2021 | 4 | 0.790 |
Why?
|
| Adult | 17 | 2021 | 8601 | 0.770 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 129 | 0.770 |
Why?
|
| Nerve Net | 1 | 2021 | 54 | 0.770 |
Why?
|
| Stents | 3 | 2005 | 76 | 0.760 |
Why?
|
| Gray Matter | 1 | 2021 | 56 | 0.760 |
Why?
|
| Intraoperative Care | 2 | 2017 | 44 | 0.750 |
Why?
|
| Temporal Lobe | 1 | 2021 | 105 | 0.740 |
Why?
|
| Postoperative Complications | 3 | 2016 | 957 | 0.730 |
Why?
|
| Cochlear Implants | 1 | 2020 | 30 | 0.730 |
Why?
|
| Treatment Outcome | 13 | 2023 | 3478 | 0.730 |
Why?
|
| Functional Laterality | 3 | 2018 | 91 | 0.730 |
Why?
|
| Epilepsies, Partial | 1 | 2019 | 24 | 0.710 |
Why?
|
| Brain Edema | 2 | 2016 | 22 | 0.700 |
Why?
|
| Movement | 2 | 2023 | 143 | 0.690 |
Why?
|
| Beta Rhythm | 1 | 2019 | 4 | 0.690 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 195 | 0.690 |
Why?
|
| Vancomycin | 1 | 2018 | 57 | 0.660 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 36 | 0.650 |
Why?
|
| Nerve Fibers | 1 | 2018 | 14 | 0.640 |
Why?
|
| Movement Disorders | 1 | 2019 | 141 | 0.640 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 97 | 0.610 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2017 | 7 | 0.610 |
Why?
|
| Epithalamus | 1 | 2016 | 3 | 0.590 |
Why?
|
| Afferent Pathways | 1 | 2016 | 5 | 0.590 |
Why?
|
| Cognition | 4 | 2023 | 1277 | 0.590 |
Why?
|
| Neurilemmoma | 1 | 2016 | 13 | 0.590 |
Why?
|
| Craniotomy | 1 | 2016 | 23 | 0.580 |
Why?
|
| Lymphangioma | 1 | 2016 | 3 | 0.570 |
Why?
|
| Critical Care Nursing | 1 | 2016 | 12 | 0.560 |
Why?
|
| Neurosciences | 1 | 2016 | 10 | 0.560 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 26 | 0.550 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2016 | 34 | 0.540 |
Why?
|
| Decompressive Craniectomy | 1 | 2015 | 3 | 0.530 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 402 | 0.530 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 62 | 0.530 |
Why?
|
| Intracranial Aneurysm | 2 | 2005 | 30 | 0.520 |
Why?
|
| Embolization, Therapeutic | 2 | 2005 | 26 | 0.520 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 145 | 0.480 |
Why?
|
| Feasibility Studies | 3 | 2022 | 227 | 0.450 |
Why?
|
| Retrospective Studies | 6 | 2021 | 3273 | 0.450 |
Why?
|
| Glioma | 3 | 2021 | 47 | 0.440 |
Why?
|
| Adolescent | 4 | 2021 | 2279 | 0.440 |
Why?
|
| Workflow | 2 | 2023 | 13 | 0.420 |
Why?
|
| Brain Neoplasms | 3 | 2021 | 124 | 0.410 |
Why?
|
| Stroke | 1 | 2015 | 293 | 0.400 |
Why?
|
| Brain Mapping | 3 | 2021 | 195 | 0.380 |
Why?
|
| Young Adult | 3 | 2021 | 1932 | 0.360 |
Why?
|
| Hypothalamus, Posterior | 1 | 2009 | 1 | 0.350 |
Why?
|
| Sex Factors | 2 | 2021 | 496 | 0.350 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 1 | 2008 | 4 | 0.330 |
Why?
|
| Hemostasis, Surgical | 1 | 2008 | 15 | 0.330 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 4851 | 0.330 |
Why?
|
| Collagen | 1 | 2008 | 102 | 0.320 |
Why?
|
| Prevalence | 2 | 2021 | 487 | 0.320 |
Why?
|
| Neuroimaging | 2 | 2019 | 136 | 0.320 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2007 | 2 | 0.320 |
Why?
|
| Decompression, Surgical | 2 | 2005 | 141 | 0.300 |
Why?
|
| Cranial Sinuses | 1 | 2005 | 5 | 0.270 |
Why?
|
| Wounds, Penetrating | 1 | 2005 | 10 | 0.270 |
Why?
|
| Parietal Lobe | 1 | 2005 | 21 | 0.270 |
Why?
|
| Brown-Sequard Syndrome | 1 | 2005 | 4 | 0.270 |
Why?
|
| Middle Cerebral Artery | 1 | 2005 | 9 | 0.270 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2005 | 9 | 0.270 |
Why?
|
| Pituitary Apoplexy | 1 | 2005 | 2 | 0.270 |
Why?
|
| Epidermal Cyst | 1 | 2005 | 6 | 0.270 |
Why?
|
| Glucosylceramidase | 2 | 2022 | 26 | 0.260 |
Why?
|
| Sphenoid Sinus | 1 | 2005 | 15 | 0.260 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2005 | 15 | 0.260 |
Why?
|
| Carotid Artery, Internal | 1 | 2005 | 11 | 0.260 |
Why?
|
| Aneurysm | 1 | 2005 | 11 | 0.260 |
Why?
|
| Spinal Stenosis | 1 | 2005 | 52 | 0.260 |
Why?
|
| Laminectomy | 1 | 2005 | 64 | 0.260 |
Why?
|
| Evoked Potentials, Motor | 2 | 2022 | 10 | 0.250 |
Why?
|
| Electric Stimulation | 2 | 2019 | 83 | 0.250 |
Why?
|
| Obesity | 1 | 2007 | 291 | 0.250 |
Why?
|
| Hippocampus | 2 | 2021 | 274 | 0.250 |
Why?
|
| Cervical Vertebrae | 2 | 2005 | 349 | 0.250 |
Why?
|
| Paresthesia | 1 | 2023 | 6 | 0.230 |
Why?
|
| Dysarthria | 1 | 2023 | 5 | 0.230 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 42 | 0.230 |
Why?
|
| Heparin | 1 | 2002 | 26 | 0.220 |
Why?
|
| Brain Chemistry | 1 | 2002 | 47 | 0.220 |
Why?
|
| Eye Movements | 1 | 2022 | 20 | 0.220 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2022 | 9 | 0.220 |
Why?
|
| Suction | 1 | 2022 | 41 | 0.210 |
Why?
|
| Plaque, Amyloid | 1 | 2002 | 144 | 0.210 |
Why?
|
| Heterozygote | 1 | 2022 | 103 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 1 | 2002 | 294 | 0.190 |
Why?
|
| Anticonvulsants | 2 | 2019 | 109 | 0.190 |
Why?
|
| Globus Pallidus | 1 | 2020 | 31 | 0.190 |
Why?
|
| Connectome | 1 | 2020 | 14 | 0.180 |
Why?
|
| Age Factors | 2 | 2018 | 843 | 0.180 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 1830 | 0.170 |
Why?
|
| Neuropsychological Tests | 2 | 2022 | 1251 | 0.170 |
Why?
|
| Infant | 1 | 2021 | 531 | 0.170 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 38 | 0.170 |
Why?
|
| Child, Preschool | 1 | 2021 | 642 | 0.170 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2018 | 36 | 0.170 |
Why?
|
| Headache | 2 | 2011 | 43 | 0.160 |
Why?
|
| Seizures | 1 | 2018 | 87 | 0.160 |
Why?
|
| Habenula | 1 | 2016 | 3 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 219 | 0.150 |
Why?
|
| Operative Time | 1 | 2017 | 80 | 0.150 |
Why?
|
| Case-Control Studies | 2 | 2017 | 638 | 0.150 |
Why?
|
| Dystonic Disorders | 1 | 2016 | 29 | 0.140 |
Why?
|
| Child | 1 | 2021 | 1346 | 0.140 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2017 | 60 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2017 | 135 | 0.140 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 9 | 0.130 |
Why?
|
| Databases, Bibliographic | 1 | 2015 | 11 | 0.130 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 12 | 0.130 |
Why?
|
| Hematoma, Subdural | 1 | 2015 | 9 | 0.130 |
Why?
|
| Illinois | 1 | 2016 | 241 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 184 | 0.130 |
Why?
|
| Acute Disease | 2 | 2005 | 226 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 788 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2018 | 1939 | 0.120 |
Why?
|
| Electromyography | 2 | 2022 | 78 | 0.120 |
Why?
|
| Radiography | 2 | 2005 | 678 | 0.110 |
Why?
|
| Aging | 1 | 2002 | 1593 | 0.110 |
Why?
|
| Disease Models, Animal | 2 | 2007 | 724 | 0.110 |
Why?
|
| Neurons | 2 | 2020 | 374 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 487 | 0.100 |
Why?
|
| Mutation | 2 | 2022 | 383 | 0.090 |
Why?
|
| Cluster Headache | 1 | 2009 | 1 | 0.090 |
Why?
|
| Red Nucleus | 1 | 2009 | 1 | 0.090 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 2009 | 6 | 0.090 |
Why?
|
| Evoked Potentials | 1 | 2009 | 18 | 0.090 |
Why?
|
| Electrophysiology | 1 | 2009 | 129 | 0.090 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2008 | 3 | 0.090 |
Why?
|
| Drinking | 1 | 2007 | 5 | 0.080 |
Why?
|
| Eating | 1 | 2007 | 45 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 451 | 0.070 |
Why?
|
| Animals | 2 | 2007 | 4552 | 0.070 |
Why?
|
| Construction Materials | 1 | 2005 | 3 | 0.070 |
Why?
|
| Fascia | 1 | 2005 | 9 | 0.070 |
Why?
|
| Cervical Plexus | 1 | 2005 | 2 | 0.070 |
Why?
|
| Paralysis | 1 | 2005 | 19 | 0.070 |
Why?
|
| Spinal Nerve Roots | 1 | 2005 | 29 | 0.070 |
Why?
|
| Diplopia | 1 | 2005 | 5 | 0.070 |
Why?
|
| Rats | 1 | 2007 | 854 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2005 | 106 | 0.060 |
Why?
|
| Equipment Design | 1 | 2005 | 185 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 364 | 0.060 |
Why?
|
| Cadaver | 1 | 2005 | 359 | 0.060 |
Why?
|
| Cholinesterases | 1 | 2002 | 1 | 0.060 |
Why?
|
| Chymotrypsin | 1 | 2002 | 3 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2005 | 1811 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2002 | 82 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 391 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2002 | 230 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2002 | 337 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 20 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2022 | 330 | 0.050 |
Why?
|
| Dyskinesias | 1 | 2020 | 35 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2020 | 503 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 45 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 662 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1442 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1113 | 0.030 |
Why?
|
| Valproic Acid | 1 | 2011 | 30 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 68 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 108 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 140 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 328 | 0.020 |
Why?
|
| Educational Status | 1 | 2011 | 295 | 0.020 |
Why?
|
| Medical Records | 1 | 2008 | 29 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 959 | 0.020 |
Why?
|